Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: A 15-year retrospective study

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 5, 2014, Pages 396-405

  Di Dalmazi, Guido ^a   Vicennati, Valentina ^a   Garelli, Silvia ^a   Casadio, Elena ^a   Rinaldi, Eleonora ^a   Giampalma, Emanuela ^a   Mosconi, Cristina ^a   Golfieri, Rita ^a   Paccapelo, Alexandro ^a   Pagotto, Uberto ^a   Pasquali, Renato ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADRENAL INCIDENTALOMA; ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; FEMALE; FOLLOW UP; HORMONE DETERMINATION; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; ITALY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; SURVIVAL RATE; ADRENAL TUMOR; CARDIOVASCULAR DISEASES; COMPLICATION; MIDDLE AGED; MORTALITY; SECRETION (PROCESS); CANCER MORTALITY; INTERMEDIATE PHENOTYPE ADRENAL INCIDENTALOMA; NONSECRETING ADRENAL INCIDENTALOMA; RISK FACTOR; SUBCLINICAL CUSHING SYNDROME; TUMOR CLASSIFICATION;

ADRENAL GLAND NEOPLASMS; AGED; CARDIOVASCULAR DISEASES; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES;

EID: 84899980689     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70211-0     Document Type: Article

References (35)

1. Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 2000, 85:637-644. on behalf of the Study Group on Adrenal Tumors of the Italian Society of Endocrinology.
2. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 2002, 19:1-25. NIH Consensus Development Program.
3. Reincke M Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000, 29:43-56.
4. Terzolo M, Stigliano A, Chiodini I, et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011, 164:851-870.
5. Erbil Y, Ademoǧlu E, Ozbey N, et al. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World J Surg 2006, 30:1665-1671.
6. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B Incidentally discovered adrenal masses. Endocr Rev 1995, 16:460-484.
7. Chiodini I, Guglielmi G, Battista C, et al. Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status. J Clin Endocrinol Metab 2004, 89:2237-2241.
8. Di Dalmazi G, Vicennati V, Rinaldi E, et al. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. Eur J Endocrinol 2012, 166:669-677.
9. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ State-of-the-art adrenal imaging. Radiographics 2001, 21:995-1012.
10. 1993 guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993, 11:905-918. Guidelines sub-committee.
11. Whitworth JA 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003, 21:1983-1992. for the World Health Organization/International Society of Hypertension writing group.
12. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007, 25:1751-1762. on behalf of the ESH-ESC task force on the management of arterial hypertension.
13. Frohlich ED, Apstein C, Chobanian AV, et al. The heart in hypertension. N Engl J Med 1992, 327:998-1008.
14. Measuring obesity: classification and description of anthropometric data 1988, WHO, World Health Organization, Copenhagen.
15. Vicennati V, Pasqui F, Cavazza C, Pagotto U, Pasquali R Stress related development of obesity and cortisol in women. Obesity 2009, 17:1678-1683.
16. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197. Anon.
17. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(suppl 1):S62-S69. American Diabetes Association.
18. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
19. Zeiger MA, Thompson GB, Duh QY, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 2009, 15(suppl 1):1-20. on behalf of the American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons.
20. Vicennati V, Ceroni L, Genghini S, Patton L, Pagotto U, Pasquali R Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. Obesity 2006, 14:235-243.
21. Barry MK, van Heerden JA, Farely DR, Grant CS, Thompson GB, Ilstrup DM Can adrenal incidentalomas be safely observed?. World J Surg 1998, 22:599-604.
22. Sirén J, Tervahartiala P, Sivula A, Haapiainen R Natural course of adrenal incidentalomas: seven-year follow-up study. World J Surg 2000, 24:579-582.
23. Sereg M, Szappanos A, Toke J, et al. Atherosclerotic risk factors and complications in patients with non-functioning adrenal adenomas treated with or without adrenalectomy: a long-term follow-up study. Eur J Endocrinol 2009, 160:647-655.
24. De Leo M, Pivonello R, Auriemma RS, et al. Cardiovascular disease in Cushing's syndrome: heart versus vasculature. Neuroendocrinology 2010, 92:50-54.
25. Graversen D, Vestergaard P, Stochholm K, Gravholt CH, Jørgensen JO Mortality in Cushing's syndrome: a systematic review and meta-analysis. Eur J Intern Med 2012, 23:278-282.
26. Rizzoni D, Porteri E, De Ciuceis C, et al. Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. J Clin Endocrinol Metab 2009, 94:5010-5018.
27. Mihailidou AS, Loan Le TY, Mardini M, Funder JW Glucocorticoids activate cardiac mineralocorticoid receptors during experimental myocardial infarction. Hypertension 2009, 54:1306-1312.
28. Schramm TK, Gislason GH, Køber L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3·3 million people. Circulation 2008, 117:1945-1954.
29. Ho JE, Paultre F, Mosca L Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project. Stroke 2003, 34:2812-2816. the Women's Pooling Project.
30. Vogelzangs N, Beekman ATF, Milaneschi Y, Bandinelli S, Ferrucci L, Penninx BWJH Urinary cortisol and six-year risk of all-cause and cardiovascular mortality. J Clin Endocrinol Metab 2010, 95:4959-4964.
31. Kumari M, Shipley M, Stafford M, Kivimaki M Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II Study. J Clin Endocrinol Metab 2011, 96:1478-1485.
32. Vassilatou E, Vryonidou A, Michalopoulou S, et al. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol 2009, 70:674-679.
33. Giordano R, Marinazzo E, Berardelli R, et al. Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol 2010, 162:779-785.
34. Yener S, Ertilav S, Secil M, et al. Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest 2010, 33:32-36.
35. Barzon L, Fallo F, Sonino N, Boscaro M Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol 2002, 146:61-66.